急性缺血性卒中串联病变的急诊管理
基于STRATIS前瞻性非随机研究984例患者中147例(14.9%)串联病变者的分析,比较取栓时是否同期支架置入颅外病变:支架组80例、非支架组67例。支架组90天良好结局(改良Rankin量表0-2分)为68.5% vs 42.2%(P=0.003),死亡或症状性出血无差异;校正协变量后支架置入仍与更优结局相关。
要点
- 串联病变取栓时同期支架置入颅外颈动脉狭窄与不置入安全性相当,死亡或症状性出血无差异。
- 支架组90天良好结局68.5% vs 非支架组42.2%(P=0.003),校正协变量后仍与更优结局相关。
- 急性期颈动脉支架置入可能带来更好结局,理想情况下应由随机试验确认。
核心结论
- 神经取栓时对颅外颈动脉狭窄行急性支架置入可达到与不置入相当的安全性。
- 急性期颈动脉支架置入可能带来更好结局,理想情况下应由随机试验确认。
研究设计与样本
- STRATIS注册研究为前瞻性非随机研究,纳入55个中心共984例使用Solitaire装置行神经取栓的患者。
- 其中147例(14.9%)为串联病变,取栓时行颅外病变支架置入80例、未置入67例。
- 采用单因素和多因素逻辑回归评估结局与手术技术的关系。
主要发现
- 支架组与非支架组在年龄、ASPECTS(Alberta卒中项目早期CT评分)或静脉tPA(组织型纤溶酶原激活剂)使用方面无差异。
- 支架组基线美国国立卫生研究院卒中量表评分较低(16 vs 17.9;P=0.07),发病至动脉穿刺时间较短(133.6 vs 163.4分钟;P=0.04)。
- 支架组心房颤动发生率较低(6.3% vs 25.4%)。
- 支架组90天良好结局(改良Rankin量表0-2分)较高(68.5% vs 42.2%;P=0.003),死亡或症状性出血无差异。
- 校正协变量后,支架置入仍与更优结局相关。
临床怎么用
- 神经取栓时对颅外颈动脉狭窄行急性支架置入可达到与不置入相当的安全性。
- 作者认为急性期颈动脉支架置入可能带来更好结局,理想情况下应由随机试验确认。
局限性
- 原文为前瞻性非随机研究,非随机设计可能引入选择偏倚。
- 原文结论指出理想情况下应由随机试验确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Although intracranial thrombectomy represents the standard treatment approach for anterior circulation tandem occlusions, whether the extracranial lesion requires acute stenting remains unclear. Our aim was to investigate differences in clinical and procedural outcomes related to stenting extracranial lesions in a registry of patients undergoing thrombectomy for acute stroke. Methods- Data were analyzed from the STRATIS registry (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke)-a prospective, nonrandomized study of patients undergoing neurothrombectomy with the Solitaire device. A total of 984 patients treated at 55 sites were analyzed. Univariate and multivariable logistic regression was used to assess relationship between outcome and procedural technique. Results- Of 147 (14.9%) patients with tandem lesions treated, stenting of the extracranial lesion during thrombectomy was performed in 80 patients and withheld in 67 patients. There were no differences between groups with respect to age, ASPECTS (Alberta Stroke Program Early CT Score), or intravenous-tPA (tissue-type plasminogen activator) use. However, the patients in the stenting group had lower baseline National Institutes of Health Stroke Scale (16 versus 17.9; P=0.07), shorter onset to arterial puncture time (133.6 versus 163.4 minutes; P=0.04), and lower rates of atrial fibrillation (6.3% versus 25.4%) as compared to the nonstenting group. Good outcomes (modified Rankin Scale, 0-2 at 90 days) were higher in the stenting group (68.5% versus 42.2%; P=0.003) with no difference in mortality or symptomatic hemorrhage. After adjustment for covariates, stenting continued to be associated with superior outcomes. Conclusions- Acute stenting of an extracranial carotid stenosis during neurothrombectomy can be achieved with equal safety compared with no stenting. Carotid stenting in the acute phase may lead to better outcomes; this should ideally be confirmed by randomized trials.
引用
- Jadhav AP, Zaidat OO, Liebeskind DS, et al. Emergent Management of Tandem Lesions in Acute Ischemic Stroke. Stroke. 2019. PMID: 30580729. doi:10.1161/STROKEAHA.118.021893
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。